{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:08:58Z","timestamp":1792800538623,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.vaccine.2018.07.075","type":"journal-article","created":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T18:21:06Z","timestamp":1535998866000},"page":"6212-6222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Replication deficient human adenovirus vector serotype 19a\/64: Immunogenicity in mice and female cynomolgus macaques"],"prefix":"10.1016","volume":"36","author":[{"given":"Emeline","family":"Ragonnaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Schroedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silmi","family":"Mariya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diah","family":"Iskandriati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joko","family":"Pamungkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrielle","family":"Fougeroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Daradoumis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan R.","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lasse","family":"Neukirch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsolt","family":"Ruzsics","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Salomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Thirion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.07.075_b0005","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ymthe.2004.07.013","article-title":"Adenoviruses as vaccine vectors","volume":"10","author":"Tatsis","year":"2004","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2018.07.075_b0010","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1128\/JVI.77.1.799-803.2003","article-title":"Overcoming immunity to a viral vaccine by DNA priming before vector boosting","volume":"77","author":"Yang","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.07.075_b0015","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1128\/JVI.77.11.6305-6313.2003","article-title":"Comparative immunogenicity in rhesus monkeys of DNA plasmid, recombinant vaccinia virus, and replication-defective adenovirus vectors expressing a human immunodeficiency virus type 1 gag gene","volume":"77","author":"Casimiro","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.07.075_b0020","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(08)61592-5","article-title":"HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis","volume":"372","author":"McElrath","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2018.07.075_b0025","first-page":"351","article-title":"Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States","volume":"11","author":"Nwanegbo","year":"2004","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2018.07.075_b0030","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.4049\/jimmunol.172.10.6290","article-title":"Immunogenicity of recombinant adenovirus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity","volume":"172","author":"Barouch","year":"2004","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.07.075_b0035","doi-asserted-by":"crossref","first-page":"8263","DOI":"10.1128\/JVI.77.15.8263-8271.2003","article-title":"Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity","volume":"77","author":"Vogels","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.07.075_b0040","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1128\/JVI.02696-06","article-title":"Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D","volume":"81","author":"Abbink","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.07.075_b0045","doi-asserted-by":"crossref","first-page":"7344","DOI":"10.1016\/j.vaccine.2015.10.023","article-title":"Combination recombinant simian or chimpanzee adenoviral vectors for vaccine development","volume":"33","author":"Cheng","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.075_b0050","doi-asserted-by":"crossref","first-page":"6562","DOI":"10.1128\/JVI.77.11.6562-6566.2003","article-title":"Extensive cross-reactivity of CD4+ adenovirus-specific T cells: implications for immunotherapy and gene therapy","volume":"77","author":"Heemskerk","year":"2003","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.07.075_b0055","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.4049\/jimmunol.1103717","article-title":"Type I IFN induced by adenovirus serotypes 28 and 35 has multiple effects on T cell immunogenicity","volume":"188","author":"Johnson","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.07.075_b0060","first-page":"115ra2","article-title":"Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species","volume":"4","author":"Colloca","year":"2012","journal-title":"SciTranslMed"},{"key":"10.1016\/j.vaccine.2018.07.075_b0065","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1089\/hum.2006.17.193","article-title":"Adenovirus vectors based on human adenovirus type 19a have high potential for human muscle-directed gene therapy","volume":"17","author":"Thirion","year":"2006","journal-title":"Hum Gene Ther"},{"key":"10.1016\/j.vaccine.2018.07.075_b0070","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1006\/viro.2002.1404","article-title":"The novel early region 3 protein E3\/49K is specifically expressed by adenoviruses of subgenus D: implications for epidemic keratoconjunctivitis and adenovirus evolution","volume":"296","author":"Blusch","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.07.075_b0075","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.virusres.2008.10.001","article-title":"Human adenovirus type 19: genomic and bioinformatics analysis of a keratoconjunctivitis isolate","volume":"139","author":"Robinson","year":"2009","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2018.07.075_b0080","doi-asserted-by":"crossref","first-page":"8100","DOI":"10.1128\/JVI.00687-06","article-title":"Transposon-assisted cloning and traceless mutagenesis of adenoviruses: development of a novel vector based on species D","volume":"80","author":"Ruzsics","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.07.075_b0085","series-title":"The potential of a novel Adenovirus vector for vaccination","author":"Stuart","year":"2010"},{"key":"10.1016\/j.vaccine.2018.07.075_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.virol.2004.11.014","article-title":"In vitro dendritic cell infection by pseudotyped adenoviral vectors does not correlate with their in vivo immunogenicity","volume":"332","author":"Hsu","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.07.075_b0095","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/CJI.0000000000000153","article-title":"Therapeutic vaccine against primate papillomavirus infections of the cervix","volume":"40","author":"Ragonnaud","year":"2017","journal-title":"J Immunother"},{"key":"10.1016\/j.vaccine.2018.07.075_b0100","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.virol.2009.07.012","article-title":"Genomic diversity and interspecies host infection of alpha12 Macaca fascicularis papillomaviruses (MfPVs)","volume":"393","author":"Chen","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.07.075_b0105","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1128\/JVI.00233-07","article-title":"Characterization and experimental transmission of an oncogenic papillomavirus in female macaques","volume":"81","author":"Wood","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.07.075_b0110","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.4049\/jimmunol.180.5.3339","article-title":"MHC class II-associated invariant chain linkage of antigen dramatically improves cell-mediated immunity induced by adenovirus vaccines","volume":"180","author":"Holst","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.07.075_b0115","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1099\/vir.0.002105-0","article-title":"Fusion of a viral antigen to invariant chain leads to augmented T-cell immunity and improved protection in gene-gun DNA-vaccinated mice","volume":"90","author":"Grujic","year":"2009","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.07.075_b0120","doi-asserted-by":"crossref","first-page":"261ra153","DOI":"10.1126\/scitranslmed.3009185","article-title":"A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory","volume":"6","author":"Swadling","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.vaccine.2018.07.075_b0125","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1038\/ncomms3836","article-title":"Protective CD8+ T-cell immunity to human malaria induced by chimpanzee adenovirus-MVA immunisation","volume":"4","author":"Ewer","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2018.07.075_b0130","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nature10766","article-title":"Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys","volume":"482","author":"Barouch","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2018.07.075_b0135","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-1-62703-679-5_11","article-title":"Engineering adenovirus genome by bacterial artificial chromosome (BAC) technology","volume":"1089","author":"Ruzsics","year":"2014","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2018.07.075_b0140","first-page":"389","article-title":"Construction of first-generation adenoviral vectors","volume":"69","author":"Ng","year":"2002","journal-title":"Methods Mol Med"},{"key":"10.1016\/j.vaccine.2018.07.075_b0145","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.vaccine.2015.06.087","article-title":"An adenoviral cancer vaccine co-encoding a tumor associated antigen together with secreted 4\u20131BBL leads to delayed tumor progression","volume":"34","author":"Ragonnaud","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.075_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/S0091-679X(08)60603-2","article-title":"Use of recombinant adenovirus for metabolic engineering of mammalian cells","volume":"43","author":"Becker","year":"1994","journal-title":"Methods Cell Biol"},{"key":"10.1016\/j.vaccine.2018.07.075_b0155","first-page":"77","article-title":"Construction and isolation of recombinant MVA","volume":"269","author":"Staib","year":"2004","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.vaccine.2018.07.075_b0160","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1038\/mt.2014.15","article-title":"Fusion of HCV nonstructural antigen to MHC class II-associated invariant chain enhances T-cell responses induced by vectored vaccines in nonhuman primates","volume":"22","author":"Capone","year":"2014","journal-title":"Mol Ther"},{"key":"10.1016\/j.vaccine.2018.07.075_b0165","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.4049\/jimmunol.0903894","article-title":"The role of CD80\/CD86 in generation and maintenance of functional virus-specific CD8+ T cells in mice infected with lymphocytic choriomeningitis virus","volume":"185","author":"Grujic","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.07.075_b0170","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1128\/JVI.00465-13","article-title":"Qualitative and quantitative analysis of adenovirus type 5 vector-induced memory CD8 T cells: not as bad as their reputation","volume":"87","author":"Steffensen","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.07.075_b0175","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.4049\/jimmunol.1301290","article-title":"Adenovirus-based vaccine against Listeria monocytogenes: extending the concept of invariant chain linkage","volume":"191","author":"Jensen","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.07.075_b0180","doi-asserted-by":"crossref","first-page":"e100538","DOI":"10.1371\/journal.pone.0100538","article-title":"Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain","volume":"9","author":"Spencer","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.07.075_b0185","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.4049\/jimmunol.1001877","article-title":"Enhanced and sustained CD8+ T cell responses with an adenoviral vector-based hepatitis C virus vaccine encoding NS3 linked to the MHC class II chaperone protein invariant chain","volume":"186","author":"Mikkelsen","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.07.075_b0190","doi-asserted-by":"crossref","first-page":"6723","DOI":"10.1016\/j.vaccine.2009.08.104","article-title":"Mucosal immunization with recombinant adenoviral vectors expressing murine gammaherpesvirus-68 genes M2 and M3 can reduce latent viral load","volume":"27","author":"Hoegh-Petersen","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.07.075_b0195","doi-asserted-by":"crossref","first-page":"e34884","DOI":"10.1371\/journal.pone.0034884","article-title":"Pre-existing vector immunity does not prevent replication deficient adenovirus from inducing efficient CD8 T-cell memory and recall responses","volume":"7","author":"Steffensen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.07.075_b0200","doi-asserted-by":"crossref","DOI":"10.1111\/sji.12522","article-title":"Breadth of T cell responses after immunization with adenovirus vectors encoding ancestral antigens or polyvalent papillomavirus antigens","author":"Ragonnaud","year":"2017","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.vaccine.2018.07.075_b0205","article-title":"Means and methods to increase adenovirus production","author":"Thirion","year":"2015","journal-title":"Google Patents"},{"key":"10.1016\/j.vaccine.2018.07.075_b0210","doi-asserted-by":"crossref","first-page":"4431","DOI":"10.4049\/jimmunol.0900537","article-title":"Quality of the transgene-specific CD8+ T cell response induced by adenoviral vector immunization is critically influenced by virus dose and route of vaccination","volume":"184","author":"Holst","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.07.075_b0215","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ebiom.2017.03.003","article-title":"Mucosal vaccination with heterologous viral vectored vaccine targeting subdominant SIV accessory antigens strongly inhibits early viral replication","volume":"18","author":"Xu","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2018.07.075_b0220","doi-asserted-by":"crossref","first-page":"4844","DOI":"10.1128\/JVI.02616-07","article-title":"Magnitude and phenotype of cellular immune responses elicited by recombinant adenovirus vectors and heterologous prime-boost regimens in rhesus monkeys","volume":"82","author":"Liu","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.07.075_b0225","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1093\/ajcp\/102.6.768","article-title":"Immunological events in regressing genital warts","volume":"102","author":"Coleman","year":"1994","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.vaccine.2018.07.075_b0230","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/ng0294-157","article-title":"HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity","volume":"6","author":"Apple","year":"1994","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2018.07.075_b0235","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2174\/157016210793499240","article-title":"The impact of HAART on HPV-related cervical disease","volume":"8","author":"Adler","year":"2010","journal-title":"Curr HIV Res"},{"key":"10.1016\/j.vaccine.2018.07.075_b0240","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-9378-4-11","article-title":"The influence of human papillomavirus type and HIV status on the lymphomononuclear cell profile in patients with cervical intraepithelial lesions of different severity","volume":"4","author":"Goncalves","year":"2009","journal-title":"Infect Agent Cancer"},{"key":"10.1016\/j.vaccine.2018.07.075_b0245","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/intimm\/9.4.591","article-title":"Peripheral blood CD4+CD8+ lymphocytes in cynomolgus monkeys are of resting memory T lineage","volume":"9","author":"Akari","year":"1997","journal-title":"Int Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18310958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18310958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:29:01Z","timestamp":1759400941000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18310958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":49,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S0264410X18310958"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.07.075","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Replication deficient human adenovirus vector serotype 19a\/64: Immunogenicity in mice and female cynomolgus macaques","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.07.075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}